Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures
Status:
Completed
Trial end date:
2019-10-22
Target enrollment:
Participant gender:
Summary
This is a phase II, single centre, randomised, parallel-group, double-blind, three doses,
placebo-controlled, exploratory efficacy and safety study. The objective of this study is to
investigate the efficacy and safety of a single intrathecal injection of Paracetamol 3% (30
mg/mL) administered at 3 doses to 3 active treatment groups, as compared to placebo, for
post-operative analgesia in knee procedures up to 40 min duration performed under spinal
anaesthesia with Chloroprocaine HCl 1%.